As of Nov 15
| +0.24 / +0.55%|
The 19 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 46.08, with a high estimate of 54.22 and a low estimate of 41.56. The median estimate represents a +4.51% increase from the last price of 44.09.
The current consensus among 23 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.